• Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Aurinia Pharmaceuticals inc

+ Add to Watchlist

AUP:CN

3.8900 CAD 0.2900 8.06%

As of 15:57:41 ET on 09/19/2014.

Snapshot for Aurinia Pharmaceuticals inc (AUP)

Open: 3.8300 Day's Range: 3.6100 - 3.8900 Volume: 2,204
Previous Close: 3.6000 52wk Range: 2.0000 - 4.8500 1-Yr Rtn: +94.50%

Stock Chart for AUP

No chart data available.
  • AUP:CN 3.8900
  • 1D
  • 1M
  • 1Y
3.6000
Interactive AUP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AUP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPTSX -
Earnings Per Share (CAD) (ttm) -1.0655
Est. EPS (CAD) (12/2014) -0.6000
Est. PEG Ratio -
Market Cap (M CAD) 122.53
Shares Outstanding (M) 31.50
30 Day Average Volume 13,347
Price/Book (mrq) 2.2400
Price/Sale (ttm) 46.0705
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/21/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AUP

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for AUP

Aurinia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the discovery and development of immunosuppressive therapeutics.

Richard M GlickmanChairman/Co-FounderStephen W ZarubyPresident/CEO
Dennis BourgeaultCFO/SecretaryMichael R MartinCOO/Co-Founder
More Company Profile & Key Executives for AUP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil